Pemigatinib After Chemotherapy for the Treatment of Newly Diagnosed Acute Myeloid Leukemia

NCT04659616 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia

Interventions

PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Aspirate
PROCEDURE: Bone Marrow Biopsy
DRUG: Cytarabine
DRUG: Daunorubicin
PROCEDURE: Electrocardiography
DRUG: Pemigatinib

Sponsor

OHSU Knight Cancer Institute

Collaborators

[object Object]
[object Object]